U.S. veterans who opt for fee-for-service health systems like Medicare are less likely to receive guideline-concordant care than their counterparts in the Veterans Health Administration (VA), researchers reported in a JAMA Network Open original investigation this month.

CMS has awarded $8.6 million in funding to 30 states and the District of Columbia to help stabilize health insurance markets. The funding is part of $250 million earmarked for State Rate Review Grants to improve the process for how sates review proposed health insurance rates.

Several major pharmacy benefit managers (PBMs), functional middlemen that negotiate drug prices with manufacturers, say they’ve received no commitments from big drug makers to lower prices, The Hill reported.

The FDA announced it is taking steps to advance innovation and surveillance for medical devices through the implementation of three initiatives related to the recent user fee re-authorization, according to an Aug. 16 news release.

Days after the state of New York filed suit against the manufacturer of a powerful opioid, President Donald Trump stated he’d like to see a federal lawsuit against more opioid makers.

In a new scholarship initiative, medical students will be able to attend New York University School of Medicine tuition free, regardless of need or merit.

Arkansas’ Medicaid work requirements are facing major problems. During the first month of implementation in June and July, more than 5,000 residents failed to follow through on reporting that they actually worked 80 hours.

Senator Chuck Grassley, R-Iowa, has asked the U.S. Department of Justice for heightened scrutiny over two significant healthcare deals currently underway, citing limited competition and high drug pricing concerns in a letter.